JPRN-C000000178已完成未知
Phase II Clinical Trial to Test Efficacy and Safety of Autologous Peripheral Stem Cell Transplantation for Multiple Myeloma (C-SHOT 0401) - Clinical Trial to Test Efficacy and Safety of Autologous Peripheral Stem Cell Transplantation for Multiple Myeloma (C-SHOT 0401)
Center for Supporting Hematology-Oncology Trials (C-SHOT)0 个研究点目标入组 60 人开始时间: 2005年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Severe renal dysfunction 2. Severe cardiovascular dysfunction 3. Active infections 4. Active opportunistic infections 5. Active double cancers 6. Subjects who, in the opinion of the investigator, are not likely to participate in the study for any reason
研究者
相似试验
已完成
2 期
Phase II Clinical Trial to test efficacy and safety of relapsed APL (JALSG APL205R study)JPRN-C000000302Japan adult leukemia study group ( JALSG)20
招募中
2 期
Safety and Efficacy study of repeated MPA therapy for recurrent early stage endometrial cancer patients (JGOG2051)JPRN-jRCTs031200256Yamagami Wataru115
终止
2 期
ANZ 0502 Neoadjuvant Gemcitabinearge operable, or locally advanced breast carcinoma.Large operable, or locally advanced breast carcinoma.Cancer - BreastACTRN12606000191594ANZ Breast Cancer Trials Group Ltd.81
进行中（未招募）
1 期
Phase II Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Alemtuzumab (CAMPATH, MabCampath) in Patients with Previously Treated B Cell Chronic Lymphocytic LeukemiaEUCTR2005-005074-69-GBGenzyme Europe BV85
进行中（未招募）
1 期
Phase II Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Alemtuzumab (CAMPATH, MabCampath) in Patients with Previously Treated B Cell Chronic Lymphocytic LeukemiaB-Cell Chronic Lymphocytic LeukemiaMedDRA version: 8.1Level: LLTClassification code 10008976Term: Chronic lymphocytic leukemiaEUCTR2005-005074-69-BEGenzyme Europe BV85